Cargando…
Advances in Single-Cell Sequencing Technology and Its Applications in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and is mainly treated with chemotherapy-based combination therapy. In recent years, with the increasing development of global precision medicine, single-cell sequencing (SCS) has become one of the most promising tec...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760048/ https://www.ncbi.nlm.nih.gov/pubmed/36540278 http://dx.doi.org/10.2147/BCTT.S388534 |